
Dr Jackline Kiarie,
Director of Programmes, Amref Health Africa
One Health sectors—human, animal and environmental health systems—must work together to protect existing medicines. Experience across Africa shows operationalising One Health is essential to tackling antimicrobial resistance, but progress depends on national policies that overcome fragmented surveillance and strengthen stewardship.
Antimicrobial resistance (AMR) is often framed as a race between science and disease-causing microorganisms. Innovation in drug development is vital, but significant lead times between discovery and getting them to patients mean they cannot address today’s most urgent needs.
A more immediate priority is how countries manage, monitor and protect the medicines already available to them to extend their life and empower and engage the public on AMR risk. Drug-resistant infections move across borders through travel, trade and interconnected food systems.
A better-connected system for AMR mitigation
For that reason, One Health is a practical necessity, which over 90% of African countries have prioritised in their National Action Plans (NAPs) on AMR.1 The countries that make the greatest progress against AMR are likely to be those that successfully operationalise their NAPs on AMR to align human, animal and environmental health systems around a shared objective: preserving the effectiveness of medicines for current and future generations.
In practice, that means creating mechanisms through which health workers, veterinarians, environmental specialists, community leaders and policymakers can generate, share and act upon evidence on AMR drivers collaboratively. Several lessons emerging from our GSK-funded AMR mitigation work in Kenya and Zambia illustrate why this matters.
Surveillance must be broader than laboratory data alone
Effective monitoring of AMR drivers requires understanding of how antimicrobials are prescribed, accessed and used across different settings. Prescription practices in health facilities, antimicrobial use in livestock systems and community knowledge all provide critical information for decision-makers.
A recently conducted Point Prevalence Survey of local antimicrobial prescribing patterns in Busia County, Kenya revealed significant stewardship challenges: more than half of hospital inpatients were receiving antimicrobials, but culture and sensitivity testing informed only 6.4% of eligible prescriptions. Facilities with antimicrobial stewardship committees recorded irrational prescribing rates of just 17.2%, compared with 60.9% in facilities without them.2
Zambia’s national One Health review combined evidence from human and animal health systems, revealing limited microbiology capacity, fragmented data systems and a heavy reliance on tetracycline in veterinary medicine.3
A more immediate priority is how countries manage, monitor and protect the medicines already available to them
Policy must support stewardship efforts across One Health sectors
Building stewardship into everyday practice reduces dependence on short-term interventions and strengthens resilience. In Zambia, for example, approved antimicrobial stewardship modules are now being used to train veterinarians and veterinary paraprofessionals nationally, moving stewardship beyond policy guidelines into routine professional practice.
To help in unpacking policy into practice, Kenya and Zambia created common training guidelines for use across sectors. Human, animal and environmental health professionals were trained together using harmonised One Health approaches, helping embed AMR considerations into routine planning and coordination rather than treating them as specialist concerns.
Data for policy implementation and practice tracking
Too often, countries collect information that is never used to track policy implementation or practice. Successful approaches create direct pathways between evidence generation and decision-making, enabling institutions to adapt guidelines, target resources and respond to emerging risks.
In Busia County, Kenya, evidence from point prevalence surveys was used to inform development of three stewardship protocols covering diagnostic testing, surgical prophylaxis and the transition from intravenous to oral antibiotics.4 Zambia’s multisectoral data review moved to action. Stakeholders agreed priorities for surveillance, laboratory strengthening, diagnostic stewardship and AMR targets in national planning.
Coordination in principle to collaboration in practice
The next phase of progress will depend on whether countries can unpack existing policies to institutionalise cross-sector collaboration, continuously invest in surveillance, and in information systems, to track progress towards AMR mitigation commitments. Neither will be sufficient without multisector governance models that connect data, policy and frontline practice and produce owned actions.
[1] World Health Organization, 2025. Tackling implementation progress of AMR national action plans in the WHO African region. tinyurl.com/47htwyp6.
[2] Amref Health Africa. Point Prevalence Survey of Three Level IV and One Level V Health Facilities, Busia County, Kenya.
[3] Zambia National Public Health Institute and Antimicrobial Resistance Coordinating Committee, Zambia. National AMR/AMU Data Review January 2022-June 2025.
[4] Amref Health Africa. Point Prevalence Survey of Three Level IV and One Level V Health Facilities, Busia County, Kenya.
Global Cause